309 related articles for article (PubMed ID: 26818227)
1. Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up.
Rautio A; Boman K; Eriksson JW; Svensson MK
Diab Vasc Dis Res; 2016 May; 13(3):183-91. PubMed ID: 26818227
[TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes.
Sahli D; Eriksson JW; Boman K; Svensson MK
Thromb Res; 2009 Mar; 123(5):701-6. PubMed ID: 18945481
[TBL] [Abstract][Full Text] [Related]
3. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.
Esteghamati A; Aflatoonian M; Rad MV; Mazaheri T; Mousavizadeh M; Nakhjavani M; Noshad S
Arch Cardiovasc Dis; 2015; 108(8-9):412-9. PubMed ID: 26184866
[TBL] [Abstract][Full Text] [Related]
4. Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study.
Chung YK; Lee YJ; Kim KW; Cho RK; Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
Diab Vasc Dis Res; 2018 Jan; 15(1):24-30. PubMed ID: 29090609
[TBL] [Abstract][Full Text] [Related]
5. Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study.
Hernestål-Boman J; Norberg M; Jansson JH; Eliasson M; Eriksson JW; Lindahl B; Johansson L
Cardiovasc Diabetol; 2012 Dec; 11():152. PubMed ID: 23249721
[TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
[TBL] [Abstract][Full Text] [Related]
7. Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease.
Mueller T; Hinterreiter F; Poelz W; Haltmayer M; Dieplinger B
Vasc Med; 2016 Oct; 21(5):445-452. PubMed ID: 27067137
[TBL] [Abstract][Full Text] [Related]
8. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.
Mary A; Hartemann A; Liabeuf S; Aubert CE; Kemel S; Salem JE; Cluzel P; Lenglet A; Massy ZA; Lalau JD; Mentaverri R; Bourron O; Kamel S
Cardiovasc Diabetol; 2017 Feb; 16(1):24. PubMed ID: 28202017
[TBL] [Abstract][Full Text] [Related]
9. The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial.
Rautio A; Boman K; Gerstein HC; Hernestål-Boman J; Lee SF; Olofsson M; Mellbin LG
Diab Vasc Dis Res; 2017 Jul; 14(4):345-352. PubMed ID: 28403644
[TBL] [Abstract][Full Text] [Related]
10. Type 2 Diabetes and Cardiovascular Factors Contrasted with Fibrinolysis Disorders in the Blood of Patients with Peripheral Arterial Disease.
Wieczór R; Wieczór AM; Kulwas A; Rość D
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31336615
[No Abstract] [Full Text] [Related]
11. Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus.
Eleftheriadou I; Grigoropoulou P; Kokkinos A; Mourouzis I; Perrea D; Katsilambros N; Sfikakis PP; Tentolouris N
J Diabetes Complications; 2017 Mar; 31(3):599-604. PubMed ID: 27899247
[TBL] [Abstract][Full Text] [Related]
12. Peripheral artery disease in type 2 diabetes: the role of fibrinolysis.
Lapolla A; Piarulli F; Sartore G; Rossetti C; Martano L; Carraro P; De Paoli M; Fedele D
Thromb Haemost; 2003 Jan; 89(1):91-6. PubMed ID: 12540958
[TBL] [Abstract][Full Text] [Related]
13. Effects of percutaneous lower-extremity arterial interventions on endothelial function and inflammation response in patients with both type 2 diabetes and lower-extremity peripheral arterial disease.
Du Y; Wang F; Qi H; Ding H; Hou L; Gao Q; Tan M; Liu Y; Xing N; Sun J
Int J Clin Exp Pathol; 2015; 8(7):8115-21. PubMed ID: 26339379
[TBL] [Abstract][Full Text] [Related]
14. Alcohol Consumption Is a Risk Factor for Lower Extremity Arterial Disease in Chinese Patients with T2DM.
Yang S; Wang S; Yang B; Zheng J; Cai Y; Yang Z
J Diabetes Res; 2017; 2017():8756978. PubMed ID: 28761879
[TBL] [Abstract][Full Text] [Related]
15. Relationship of oxidative stress and fibrinolysis in diabetes mellitus.
Skrha J; Hodinár A; Kvasnicka J; Hilgertová J
Diabet Med; 1996 Sep; 13(9):800-5. PubMed ID: 8891455
[TBL] [Abstract][Full Text] [Related]
16. Association of serum C1q tumour necrosis factor-related protein 9 with the severity of lower extremity peripheral arterial disease in type 2 diabetes patients.
Jiang W; Tang Q; Zhang L; Chao Y; Hong B
Diab Vasc Dis Res; 2018 May; 15(3):270-273. PubMed ID: 29543038
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
Mansfield MW; Catto AJ; Carter AM; Grant PJ
Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Diabetic Retinopathy Stages and Risk of Major Lower-Extremity Arterial Disease in Patients With Type 2 Diabetes.
Foussard N; Saulnier PJ; Potier L; Ragot S; Schneider F; Gand E; Monlun M; Baillet-Blanco L; Velho G; Marre M; Roussel R; Rigalleau V; Mohammedi K; Hadjadj S;
Diabetes Care; 2020 Nov; 43(11):2751-2759. PubMed ID: 33055101
[TBL] [Abstract][Full Text] [Related]
19. Elevation of a novel angiogenic factor, leucine-rich-α2-glycoprotein (LRG1), is associated with arterial stiffness, endothelial dysfunction, and peripheral arterial disease in patients with type 2 diabetes.
Pek SL; Tavintharan S; Wang X; Lim SC; Woon K; Yeoh LY; Ng X; Liu J; Sum CF
J Clin Endocrinol Metab; 2015 Apr; 100(4):1586-93. PubMed ID: 25636050
[TBL] [Abstract][Full Text] [Related]
20. Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus.
Vicari AM; Viganó D'Angelo S; Testa S; Comi G; Galardi G; Orsi E; D'Angelo A
Horm Metab Res; 1992 Nov; 24(11):516-9. PubMed ID: 1452117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
